205 related articles for article (PubMed ID: 20664348)
21. A missense mutation in the alphaB-crystallin chaperone gene causes a desmin-related myopathy.
Vicart P; Caron A; Guicheney P; Li Z; Prévost MC; Faure A; Chateau D; Chapon F; Tomé F; Dupret JM; Paulin D; Fardeau M
Nat Genet; 1998 Sep; 20(1):92-5. PubMed ID: 9731540
[TBL] [Abstract][Full Text] [Related]
22. Immunoblot as a potential diagnostic tool for myofibrillar myopathies.
Marini M; Guglielmi V; Faulkner G; Piffer S; Tomelleri G; Vattemi G
Electrophoresis; 2015 Dec; 36(24):3097-100. PubMed ID: 26383991
[TBL] [Abstract][Full Text] [Related]
23. Mutations in ZASP define a novel form of muscular dystrophy in humans.
Selcen D; Engel AG
Ann Neurol; 2005 Feb; 57(2):269-76. PubMed ID: 15668942
[TBL] [Abstract][Full Text] [Related]
24. Cardiac arrhythmia and late-onset muscle weakness caused by a myofibrillar myopathy with unusual histopathological features due to a novel missense mutation in FLNC.
Avila-Smirnow D; Gueneau L; Batonnet-Pichon S; Delort F; Bécane HM; Claeys K; Beuvin M; Goudeau B; Jais JP; Nelson I; Richard P; Ben Yaou R; Romero NB; Wahbi K; Mathis S; Voit T; Furst D; van der Ven P; Gil R; Vicart P; Fardeau M; Bonne G; Behin A
Rev Neurol (Paris); 2016 Oct; 172(10):594-606. PubMed ID: 27633507
[TBL] [Abstract][Full Text] [Related]
25. How much mutant protein is needed to cause a protein aggregate myopathy in vivo? Lessons from an exceptional desminopathy.
Clemen CS; Fischer D; Reimann J; Eichinger L; Müller CR; Müller HD; Goebel HH; Schröder R
Hum Mutat; 2009 Mar; 30(3):E490-9. PubMed ID: 19105189
[TBL] [Abstract][Full Text] [Related]
26. Mutations in myotilin cause myofibrillar myopathy.
Selcen D; Engel AG
Neurology; 2004 Apr; 62(8):1363-71. PubMed ID: 15111675
[TBL] [Abstract][Full Text] [Related]
27. Clinical, morphological and genetic studies in a cohort of 21 patients with myofibrillar myopathy.
Vattemi G; Neri M; Piffer S; Vicart P; Gualandi F; Marini M; Guglielmi V; Filosto M; Tonin P; Ferlini A; Tomelleri G
Acta Myol; 2011 Oct; 30(2):121-6. PubMed ID: 22106715
[TBL] [Abstract][Full Text] [Related]
28. Expression of caveolar components in primary desminopathy.
Shinde A; Nakano S; Sugawara M; Toyoshima I; Ito H; Tanaka K; Kusaka H
Neuromuscul Disord; 2008 Mar; 18(3):215-9. PubMed ID: 18343114
[TBL] [Abstract][Full Text] [Related]
29. Zebrafish models of BAG3 myofibrillar myopathy suggest a toxic gain of function leading to BAG3 insufficiency.
Ruparelia AA; Oorschot V; Vaz R; Ramm G; Bryson-Richardson RJ
Acta Neuropathol; 2014 Dec; 128(6):821-33. PubMed ID: 25273835
[TBL] [Abstract][Full Text] [Related]
30. Expression of the intermediate filament protein synemin in myofibrillar myopathies and other muscle diseases.
Olivé M; Goldfarb L; Dagvadorj A; Sambuughin N; Paulin D; Li Z; Goudeau B; Vicart P; Ferrer I
Acta Neuropathol; 2003 Jul; 106(1):1-7. PubMed ID: 12669240
[TBL] [Abstract][Full Text] [Related]
31. In vivo characterization of mutant myotilins.
Keduka E; Hayashi YK; Shalaby S; Mitsuhashi H; Noguchi S; Nonaka I; Nishino I
Am J Pathol; 2012 Apr; 180(4):1570-80. PubMed ID: 22349301
[TBL] [Abstract][Full Text] [Related]
32. Gene-related protein surplus myopathies.
Goebel HH; Warlo I
Mol Genet Metab; 2000; 71(1-2):267-75. PubMed ID: 11001821
[TBL] [Abstract][Full Text] [Related]
33. Abnormal desmin protein in myofibrillar myopathies caused by desmin gene mutations.
Li M; Dalakas MC
Ann Neurol; 2001 Apr; 49(4):532-6. PubMed ID: 11310634
[TBL] [Abstract][Full Text] [Related]
34. Myofibrillar (desmin-related) myopathy: clinico-pathological spectrum in 3 cases and review of the literature.
Wanschit J; Nakano S; Goudeau B; Ströbel T; Rinner W; Wimmer G; Resch H; Jaksch M; Akiguchi I; Vicart P; Budka H
Clin Neuropathol; 2002; 21(5):220-31. PubMed ID: 12365725
[TBL] [Abstract][Full Text] [Related]
35. Myofibrillar myopathy caused by novel dominant negative alpha B-crystallin mutations.
Selcen D; Engel AG
Ann Neurol; 2003 Dec; 54(6):804-10. PubMed ID: 14681890
[TBL] [Abstract][Full Text] [Related]
36. BAG3-related myopathy, polyneuropathy and cardiomyopathy with long QT syndrome.
Kostera-Pruszczyk A; Suszek M; Płoski R; Franaszczyk M; Potulska-Chromik A; Pruszczyk P; Sadurska E; Karolczak J; Kamińska AM; Rędowicz MJ
J Muscle Res Cell Motil; 2015 Dec; 36(6):423-32. PubMed ID: 26545904
[TBL] [Abstract][Full Text] [Related]
37. Metformin rescues muscle function in BAG3 myofibrillar myopathy models.
Ruparelia AA; McKaige EA; Williams C; Schulze KE; Fuchs M; Oorschot V; Lacene E; Meregalli M; Lee C; Serrano RJ; Baxter EC; Monro K; Torrente Y; Ramm G; Stojkovic T; Lavoie JN; Bryson-Richardson RJ
Autophagy; 2021 Sep; 17(9):2494-2510. PubMed ID: 33030392
[TBL] [Abstract][Full Text] [Related]
38. BAG3
Robertson R; Conte TC; Dicaire MJ; Rymar VV; Sadikot AF; Bryson-Richardson RJ; Lavoie JN; O'Ferrall E; Young JC; Brais B
Am J Pathol; 2020 Mar; 190(3):554-562. PubMed ID: 31953038
[TBL] [Abstract][Full Text] [Related]
39. The Z-disk diseases.
Selcen D; Carpén O
Adv Exp Med Biol; 2008; 642():116-30. PubMed ID: 19181098
[TBL] [Abstract][Full Text] [Related]
40. [Myofibrillar myopathies].
Nakano S
Rinsho Shinkeigaku; 2012; 52(11):1151-3. PubMed ID: 23196546
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
